Dr Mark Kris continues the discussion on 5-year outcomes of neoadjuvant chemotherapy plus nivolumab in lung cancer, highlighting its curative potential and next steps.

CARBONDALE, Ill. (WSIL) -- Southern Illinois Healthcare (SIH) has introduced a groundbreaking advancement in lung care for the region. SIH Memorial Hospital of Carbondale recently performed the first ...

Rachel Feltman: For Scientific American’s Science Quickly, I’m Rachel Feltman. Lung cancer is the deadliest cancer among women in the United States, surpassing the mortality numbers of breast and ...

A health start-up is harnessing the power of beagles' extraordinary sense of smell to revolutionize early cancer detection. The company, Spot It Early, has developed a test that uses trained beagles ...

Please provide your email address to receive an email when new articles are posted on . Surgery and stereotactic ablative radiotherapy conferred comparable 10-year survival among patients with ...

Patients were randomized to receive I-DXd 8 or 12 mg/kg intravenously every 3 weeks (Q3W) in part 1 (dose optimization) and received I-DXd 12 mg/kg in part 2 (extension). The primary endpoint was ...

Young women with breast cancer often experience declines in body image and sexual satisfaction during and after treatment, necessitating comprehensive support systems. Chemotherapy and surgery can ...

Swedish activist Greta Thunberg is facing backlash after using an image of an emaciated Israeli hostage in an Instagram post allegedly showing Palestinians suffering. The post read, "The suffering of ...

Ewha Womans University Blood Cancer Hospital (Hospital Director Moon Young-chul) recently opened a cell and gene processing center capable of 'CAR-T cell therapy' and started full-scale operation, ...

Artificial intelligence is making its mark on the future of cancer care. One of the newest applications for the technology is pinpointing hard-to-detect breast cancer. Researchers at Ohio State ...